BioSpace News Archive

Press Releases

Pelthos Therapeutics to Participate in Upcoming September 2025 Investor Conferences

September 9, 2025
·
1 min read
Press Releases

Lexicon Pharmaceuticals Announces Submission of Additional Data to U.S. FDA Supporting the Benefit-Risk Profile of Zynquista® in Type 1 Diabetes

September 9, 2025
·
4 min read
Press Releases

I-Mab Announces Acceleration of Givastomig Investment and Leadership Appointments

September 9, 2025
·
8 min read
Press Releases

Atossa Therapeutics Announces Regulatory Strategy Aimed at Accelerating Development of Low-Dose (Z)-Endoxifen for Breast Cancer Risk Reduction

September 9, 2025
·
10 min read
Press Releases

MadSci Announces $10 Million Oversubscribed Seed Financing to Advance Smart Technology for Neurologic Conditions

September 9, 2025
·
3 min read
Press Releases

New 4-Year Data for Pombiliti® (cipaglucosidase alfa-atga) + Opfolda® (miglustat) Presented at ICIEM

September 9, 2025
·
9 min read
Press Releases

Tevogen Values TVGN-489 at $9–$11 Billion rNPV, Its First Clinical Product From the Proprietary ExacTcell™ Allogeneic T Cell Platform

September 9, 2025
·
4 min read
Press Releases

Femasys Secures Regulatory Approval for FemBloc® Permanent Birth Control in New Zealand

September 9, 2025
·
5 min read
Press Releases

CASI Pharmaceuticals Announces Safety Monitoring Committee Recommendation to Escalate CID-103 Dose to Next Cohort in Phase 1 Immune Thrombocytopenia (ITP) Study

September 9, 2025
·
7 min read
Press Releases

Remedium Bio Announces Strategic Collaboration With Lilly to Develop Gene Therapies for Obesity and Type 2 Diabetes

September 9, 2025
·
2 min read